Home › Uterine Cancer › New York
Uterine Cancer clinical trials in New York
8 studies for Uterine Cancer are looking for participants at sites in New York.
Cities in New York
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
- Maimonides Medical Center, Brooklyn
- Columbia University Medical Center - Herbert Irving Pavilion, New York
- IP Address: Columbia University Medical Center/New York Presbyterian Hospital Research Pharmacy, New York
RecruitingPhase 4
Ages 18 and older · Women · Updated Sep 25, 2026 · NCT06952660DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Research Site, New York
RecruitingPhase 3
Ages 18 and older · Women · Updated Sep 3, 2026 · NCT06989112PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
- Northwell Health Cancer Institute at Huntington, Greenlawn
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 26, 2026 · NCT04329494Investigations of Reproductive Cancers in Women
- Columbia University, New York
RecruitingObservational study
Ages 45 to 100 · Women · Updated Aug 17, 2026 · NCT06527157Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer
- Icahn School of Medicine at Mount Sinai Division of Hematology and Medical Oncology, New York
RecruitingPhase 1/2
Ages 18 and older · Women · Updated Aug 13, 2026 · NCT06040970Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- Research Site, Brooklyn
- Research Site, Stony Brook
- Research Site, The Bronx
- and 1 more
RecruitingPhase 3
Ages 18 and older · Women · Updated Jul 29, 2026 · NCT07044336A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 2
Ages 8 and older · All sexes · Updated Jul 27, 2026 · NCT05503797NYSCF Scientific Discovery Biobank
- New York Stem Cell Foundation Research Institute, New York
RecruitingObservational study
30 Days · All sexes · Updated Mar 3, 2025 · NCT06203106From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.